Navigation Links
Pediatric cardiac surgeon honored with Gibbon Award and scientific journal tribute
Date:3/15/2013

Washington, DCRichard A. Jonas, MD, Chief of Cardiac Surgery and Co-Director of the Children's National Heart Institute at Children's National Medical Center, has received the prestigious Gibbon Award from the American Society of Extra-Corporeal Technology (AmSECT).

Dr. Jonas was also honored in a tribute published in the journal Cardiology in the Young (Cambridge University Press), citing his contributions as a global leader in his field.

"These tributes, from a respected scientific society and a leading journal, are deserved recognition of Richard's skills as a surgeon, mentor, scientist, and pioneer in congenital heart disease," said Kurt D. Newman, MD, President and CEO of Children's National. "Those of us in pediatric surgery are well aware of the impact he has made on so many children worldwide, and we're delighted to see his contributions acknowledged."

The 2013 Gibbon Award was presented March 6 at AmSECT's 51st International Conference in Nevada. The Society's highest honor, the Gibbon Award recognizes an individual who has made significant contributions to the cardiopulmonary discipline interrelating with the field of extracorporeal circulation.

In addition, the journal Cardiology in the Young dedicated a special issue to Dr. Jonas to acknowledge his "tremendous contributions made to medicine." In the tribute article, author Jeffrey P. Jacobs, MD, of Johns Hopkins Children's Heart Surgery, All Children's Hospital, and Florida Hospital for Children, describes Dr. Jonas as a "a true leader among cardiac surgeons" and "a 'quintuple threat' professional, with sustained excellence in all five of these areas clinical care, teaching, research, business leadership, and alignment." The article quotes Marshall L. Jacobs, MD, of Cleveland Clinic Children's Hospital, as saying, "Richard has directly touched the lives of tens of thousands, and indirectly through his generosity as a teacher, has literally improved the lives of millions of children and their families."

"I am honored to receive the Gibbon Award, which is the highest honor in the field of perfusion," said Dr. Jonas. "Likewise, I am humbled by the generous tribute in the HeartWeek issue of Cardiology in the Young. Helping to advance pediatric cardiac surgery and mentor others in this field has been my life's work, and I hope I have helped improve the lives of children with congenital heart conditions."

Dr. Jonas is a world-renowned pediatric cardiac surgeon specializing in optimizing the developmental and cognitive outcomes of patients after surgery for congenital heart disease. He is a pioneer of corrective surgery and maintains active, NIH-supported laboratory and clinical research programs. He has trained many cardiothoracic surgery residents and fellows, and he is the author of the leading pediatric cardiovascular surgery textbook, Comprehensive Surgical Management of Congenital Heart Disease.


'/>"/>

Contact: Emily Hartman
ehartman@childrensnational.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Related medicine news :

1. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
2. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
3. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
4. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
5. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
6. Many Parents of Kids With Autism Dont Put Faith in Pediatricians
7. Pediatric epilepsy impacts sleep for the child and parents
8. Tiny Tots in the Dentists Chair Among Changes in Pediatric Dentistry
9. Pediatric kidney expert receives Young Investigator Award from American Transplant Congress
10. Pediatric regime of chemotherapy proves more effective for young adults
11. Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and Medically Underserved ... bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. The ... Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for their ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... presence in Texas with the acquisitions of two personal care service companies: Padre ... Texas City, Texas, effective January 1, 2017. , Well regarded in their respective ...
(Date:1/24/2017)... Michigan (PRWEB) , ... January 24, 2017 , ... The ... other advocates for drug and alcohol awareness, have worked with communities to designate the ... year, observed January 23-29, 2017, the theme is “Shatter the Myths.” As a ...
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate ... K-20 Education Summit to be held March 23-25, 2017 in Tampa, and reminded ... 2017. , The keynote speakers include Dr. Michelle R. Weise, executive director of ...
(Date:1/23/2017)... Dc (PRWEB) , ... January 23, 2017 , ... ... American University is taught by healthcare management and evaluation leaders with decades of ... fee-for-service to pay-for-value in the United States healthcare system, there is a renewed ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 LifeVac, the revolutionary device that has ... prevented choking deaths, welcomes Steve Way , comedian, ... team as Official Spokesperson. "We are ... said Arthur Lih , Founder and CEO of ... his mission to raise awareness about the physically disabled ...
(Date:1/23/2017)... , Jan. 23, 2017  Allergan plc, (NYSE: ... its continued support of the International Headache Academy (IHA). Designed ... neurologists and research scientists, IHA offers a three-day, intensive overview ... that Allergan has been the sole sponsor since the inception ... 2013, and iHEAD in Europe in ...
(Date:1/23/2017)... -- Varias proteínas clave que impulsan ... y el riesgo de diálisis están poco reguladas ... Resverlogix Corp. ("Resverlogix" o "la compañía") (TSX: ... en fase 1 con sede en Nueva Zelanda con ... datos demostraron unos resultados importantes en la reducción de ...
Breaking Medicine Technology: